A biotech business that has actually invested 11 years investigating supplements to increase human durability strategies to launch its supplements later this year. Longevica states it has brought in a total of $13 million from financiers, consisting of Alexander Chikunov, a longevity financier, who is also president of the business.
Longevica says it developed a biotechnology platform for longevity after researching the life-span of laboratory mice. It now aims to produce medications, dietary supplements and food.
The longevity space is a growing sector for tech start-ups. Google backed the launch of Calico in the space. Late in 2015 Humankind Inc. raised $2.5 million in a round led by Boston fund One Method Ventures for its longevity company that will take advantage of AI to maximize individuals’s health period.
Longevica’s CEO Aynar Abdrakhmanov, supporting his business’s objective to tap the desire for individuals to live longer, said: “According to the WHO, by 2050, 2 billion individuals will be 60+ years old. By 2026, the sales of services and items for this audience will be around $27 trillion… … By comparison, it was only $17 trillion in 2019.”
According to CB Insights, life-extension startups raised a record total of $800 million in 2018 alone. And there are some high-profile investors in the space.
PayPal co-founder Peter Thiel purchased Unity Biotechnology, which is developing drugs to treat diseases that accompany aging. And Ethereum founder Vitalik Buterin invested $2.4 million worth of Ether into the not-for-profit SENS Research structure, where well known longevity research study Aubrey de Grey is chief science officer, to establish restoration biotechnologies.
Longevica is basing its platform on the work of scientist Alexey Ryazanov, who holds 10 U.S. patents in the space, and is a long time researcher into the policy of protein biosynthesis cells.
Chikunov stated: “I gathered scientists understood in this field to discuss their techniques to the problem. Then Alexey Ryazanov proposed the innovative concept of large-scale screening of all known medicinal substances on long-lived mice in order to find those that lengthen life.”
Under the management of Ryazanov, Longevica states it used 20,000 long-lived female mice and 1,033 drugs representing substances from 62 pharmacological classes to find 5 substances that statistically substantially increased durability by 16-22%: Inulin, Pentetic Acid, Clofibrate, Proscillaridin A, D-Valine.
From this work, they formed a view about the elimination of specific heavy metals from the body and enhanced the body’s ability to get rid of toxins.
Article curated by RJ Shara from Source. RJ Shara is a Bay Area Radio Host (Radio Jockey) who talks about the startup ecosystem – entrepreneurs, investments, policies and more on her show The Silicon Dreams. The show streams on Radio Zindagi 1170AM on Mondays from 3.30 PM to 4 PM.
Recent Comments